159 related articles for article (PubMed ID: 11527156)
1. Genetic lesions and perturbation of chromatin architecture: a road to cell transformation.
Chakraborty S; Senyuk V; Nucifora G
J Cell Biochem; 2001; 82(2):310-25. PubMed ID: 11527156
[TBL] [Abstract][Full Text] [Related]
2. Retinoid receptors in health and disease: co-regulators and the chromatin connection.
Minucci S; Pelicci PG
Semin Cell Dev Biol; 1999 Apr; 10(2):215-25. PubMed ID: 10441075
[TBL] [Abstract][Full Text] [Related]
3. Chromatin remodeling and leukemia: new therapeutic paradigms.
Redner RL; Wang J; Liu JM
Blood; 1999 Jul; 94(2):417-28. PubMed ID: 10397708
[No Abstract] [Full Text] [Related]
4. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
[TBL] [Abstract][Full Text] [Related]
5. Histone acetyltransferase complexes.
Grant PA; Berger SL
Semin Cell Dev Biol; 1999 Apr; 10(2):169-77. PubMed ID: 10441070
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
Grimwade D; Solomon E
Curr Top Microbiol Immunol; 1997; 220():81-112. PubMed ID: 9103677
[TBL] [Abstract][Full Text] [Related]
7. Bromodomain 4: a cellular Swiss army knife.
Devaiah BN; Gegonne A; Singer DS
J Leukoc Biol; 2016 Oct; 100(4):679-686. PubMed ID: 27450555
[TBL] [Abstract][Full Text] [Related]
8. Role of p160 coactivator complex in the activation of liver X receptor.
Huuskonen J; Fielding PE; Fielding CJ
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):703-8. PubMed ID: 14764426
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid receptors: involvement in acute promyelocytic leukemia.
Agadir A; Cornic M; Gourmel B; Lefebvre P; Degos L; Chomienne C
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):263-74. PubMed ID: 7920173
[TBL] [Abstract][Full Text] [Related]
10. Activators and repressors: making use of chromatin to regulate transcription.
Wolffe AP; Wong J; Pruss D
Genes Cells; 1997 May; 2(5):291-302. PubMed ID: 9280341
[TBL] [Abstract][Full Text] [Related]
11. The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia.
Sotoca AM; Prange KH; Reijnders B; Mandoli A; Nguyen LN; Stunnenberg HG; Martens JH
Oncogene; 2016 Apr; 35(15):1965-76. PubMed ID: 26148230
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil maturation and the role of retinoic acid.
Lawson ND; Berliner N
Exp Hematol; 1999 Sep; 27(9):1355-67. PubMed ID: 10480426
[TBL] [Abstract][Full Text] [Related]
13. Chromatin remodeling: a marriage between two families?
Pollard KJ; Peterson CL
Bioessays; 1998 Sep; 20(9):771-80. PubMed ID: 9819566
[TBL] [Abstract][Full Text] [Related]
14. p300-mediated acetylation facilitates the transfer of histone H2A-H2B dimers from nucleosomes to a histone chaperone.
Ito T; Ikehara T; Nakagawa T; Kraus WL; Muramatsu M
Genes Dev; 2000 Aug; 14(15):1899-907. PubMed ID: 10921904
[TBL] [Abstract][Full Text] [Related]
15. The PML nuclear compartment and cancer.
Doucas V; Evans RM
Biochim Biophys Acta; 1996 Dec; 1288(3):M25-9. PubMed ID: 9011178
[No Abstract] [Full Text] [Related]
16. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP
Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177
[TBL] [Abstract][Full Text] [Related]
17. Nuclear receptor coactivators.
Westin S; Rosenfeld MG; Glass CK
Adv Pharmacol; 2000; 47():89-112. PubMed ID: 10582085
[No Abstract] [Full Text] [Related]
18. TLS-CHOP and the role of RNA-binding proteins in oncogenic transformation.
Ron D
Curr Top Microbiol Immunol; 1997; 220():131-42. PubMed ID: 9103679
[No Abstract] [Full Text] [Related]
19. Transcriptional activation by thyroid hormone receptor-beta involves chromatin remodeling, histone acetylation, and synergistic stimulation by p300 and steroid receptor coactivators.
Lee KC; Li J; Cole PA; Wong J; Kraus WL
Mol Endocrinol; 2003 May; 17(5):908-22. PubMed ID: 12586842
[TBL] [Abstract][Full Text] [Related]
20. TIP49 regulates beta-catenin-mediated neoplastic transformation and T-cell factor target gene induction via effects on chromatin remodeling.
Feng Y; Lee N; Fearon ER
Cancer Res; 2003 Dec; 63(24):8726-34. PubMed ID: 14695187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
